Artificial Vital Organs and Medical Bionics Market Analysis and Segment Forecasts To 2022

Table of Content

Chapter 1 Methodology and Scope
                   1.1 Research Methodology
                   1.2 Research Scope & Assumptions
                   1.3 List of Data Sources
Chapter 2 Executive Summary
Chapter 3 Artificial Vital Organ And Medical Bionics Industry Outlook
                   3.1 Market segmentation
                   3.2 Market size and growth prospects
                   3.3 Artificial vital organs and medical bionics: Market dynamics
                      3.3.1 Market driver analysis
                      3.3.2 Increase in prevalence of organ failure and disabilities
                      3.3.3 Increasing patient adoption rate and lack of donors
                      3.3.4 Technological advancements pertaining to novel product development
                      3.3.5 Market restraint analysis
                           3.3.5.1 Criticism associated with artificial organ transplant
                           3.3.5.2 High costs associated with development of artificial organs and medical bionics
                   3.4 Key Opportunities Prioritized
                   3.5 Industry analysis – Porter’s
                   3.6 Artificial vital organs and medical bionics – PESTEL Analysis
Chapter 4 Artificial Vital Organs and Medical Bionics Product Outlook
                   4.1 Artificial vital organ and medical bionics revenue share, by product, 2014 & 2022
                   4.2 Artificial vital organs market
                      4.2.1 Artificial vital organs market, 2012 – 2022 (USD Million)
                      4.2.2 Artificial heart
                           4.2.2.1 Total artificial heart (TAH)
                      4.2.3 Artificial heart market, 2012 – 2022 (USD Million)
                      4.2.4 Artificial kidney
                           4.2.4.1 Hem dialysis Machines
                      4.2.5 Artificial kidney market, 2012 – 2022 (USD Million)
                   4.3 Artificial liver
                      4.3.1 Artificial liver market, 2012 – 2022 (USD Million)
                      4.3.2 Artificial pancreas
                           4.3.2.1 Insulin Pumps
                      4.3.3 Artificial pancreas market, 2012 – 2022 (USD Million)
                      4.3.4 Artificial Lungs
                      4.3.5 Artificial lungs market, 2012 – 2022 (USD Million)
                           4.3.5.1 Heart-lung bypass machines
                           4.3.5.2 Oxygenators
                   4.4 Medical bionics
                      4.4.1 Ear bionics (cochlear Implants)
                   4.5 Vision bionics
                      4.5.1 Vision bionics market, 2012 – 2022 (USD Million)
                   4.6 Exoskeletons
                      4.6.1 Exoskeletons market, 2012 – 2022 (USD Million)
                      4.6.2 Bionic Limbs
                      4.6.3 Bionic limbs market, 2012 – 2022 (USD Million)
                           4.6.3.1 Bionic leg
                           4.6.3.2 Bionic hand
                      4.6.4 Brain bionics
                           4.6.4.1 Spinal cord stimulators
                      4.6.5 Spinal cord stimulators market, 2012 – 2022 (USD Million)
                           4.6.5.1 Deep Brain Stimulators
                      4.6.6 Deep brain stimulators market, 2012 – 2022 (USD Million)
                           4.6.6.1 Vagus Nerve Stimulators
                      4.6.7 Vagus nerve stimulators market, 2012 – 2022 (USD Million)
                      4.6.8 Cardiac bionics
                      4.6.9 Cardiac bionics market, 2012 – 2022 (USD Million)
                           4.6.9.1 Ventricular assist device (VAD)
                           4.6.9.2 Ventricular assist devices market, 2012 – 2022 (USD Million)
                                  4.6.9.2.1 Left ventricular assist devices
                                  4.6.9.2.2 Left ventricular assist devices market, 2012 – 2022 (USD Million)
                                  4.6.9.2.3 Right ventricular assist devices
                                  4.6.9.2.4 Right ventricular assist devices market, 2012 – 2022 (USD Million)
                           4.6.9.1 Heart Valves
                           4.6.9.2 Heart valves market, 2012 – 2022 (USD Million)
                                  4.6.9.2.1 Mechanical heart valves
                                  4.6.9.2.2 Mechanical heart valves market, 2012 – 2022 (USD Million)
                                  4.6.9.2.3 Biological Tissue Valves
                                  4.6.9.2.4 Biological tissue valves market, 2012 – 2022 (USD Million)
                                  4.6.9.2.5 Transcatheter heart valves
                                  4.6.9.2.6 Transcatheter heart valves market, 2012 – 2022 (USD Million)
Chapter 5 Artificial Vital Organ and Medical Bionics Regional Outlook
                   5.1 Artificial vital organ and medical bionics revenue share, by product, 2014 & 2022
                   5.2 North America
                      5.2.1 North America artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
                   5.3 Europe
                      5.3.1 Europe artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
                   5.4 Asia Pacific
                      5.4.1 Asia Pacific artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
                   5.5 RoW
                      5.5.1 RoW artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
Chapter 6 Competitive Landscape
                   6.1 Abiomed Inc.
                      6.1.1 Company Overview
                      6.1.2 Financial Performance
                      6.1.3 Product Benchmarking
                      6.1.4 Strategic Initiatives
                   6.2 Touch Bionics Inc.
                      6.2.1 Company Overview
                      6.2.2 Financial Performance
                      6.2.3 Product Benchmarking
                      6.2.4 Strategic Initiatives
                   6.3 F. Hoffmann-La Roche AG
                      6.3.1 Company Overview
                      6.3.2 Financial Performance
                      6.3.3 Product Benchmarking
                      6.3.4 Strategic Initiatives
                   6.4 Baxter Inc
                      6.4.1 Company Overview
                      6.4.2 Financial Performance
                      6.4.3 Product Benchmarking
                      6.4.4 Strategic Initiatives
                   6.5 Medtronic Plc.
                      6.5.1 Company Overview
                      6.5.2 Financial Performance
                      6.5.3 Product Benchmarking
                      6.5.4 Strategic Initiatives
                   6.6 MicroMed Cardiovascular, Inc.
                      6.6.1 Company Overview
                      6.6.2 Financial Performance
                      6.6.3 Product Benchmarking
                      6.6.4 Strategic Initiatives
                   6.7 Edwards Life Sciences Corporation
                      6.7.1 Company Overview
                      6.7.2 Financial Performance
                      6.7.3 Product Benchmarking
                      6.7.4 Strategic Initiatives
                   6.8 Frensenius Kabi.
                      6.8.1 Company Overview
                      6.8.2 Financial Performance
                      6.8.3 Product Benchmarking
                      6.8.4 Strategic Initiatives
                   6.9 Heartware International Inc
                      6.9.1 Company Overview
                      6.9.2 Financial Performance
                      6.9.3 Product Benchmarking
                      6.9.4 Strategic Initiatives
                   6.10 Ottobock Healthcare
                      6.10.1 Company Overview
                      6.10.2 Financial Performance
                      6.10.3 Product Benchmarking
                      6.10.4 Strategic Initiatives

List of Tables

TABLE 1 Artificial vital organs and medical bionics market - Industry Summary & Key Buying Criteria, 2012 - 2022
TABLE 2 Global artificial vital organ and medical bionics market, by product, 2012 - 2022 (USD Million)
TABLE 3 Artificial vital organ and medical bionics market, by region, 2012 - 2022 (USD Million)
TABLE 4 Artificial vital organs and medical bionics - Key market driver analysis
TABLE 5 Artificial vital organs and medical bionics - Key market restraint analysis
TABLE 6 Key spinal cord stimulators and their product approval status
TABLE 7 Key deep brain stimulators and their product approval status
TABLE 8 Key vagus nerve stimulators and their product approval status
TABLE 9 North America artificial vital organs and medical bionics market, by product, 2012 - 2022 (USD Million)
TABLE 10 Europe artificial vital organs and medical bionics market, by product, 2012 - 2022 (USD Million)
TABLE 11 Asia Pacific artificial vital organs and medical bionics market, by product, 2012 - 2022 (USD Million)
TABLE 12 RoW artificial vital organs and medical bionics market, by product, 2012 - 2022 (USD Million)

List of Figures

FIG. 1 Artificial vital organs and medical bionics : Market segmentation
FIG. 2 Global artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
FIG. 3 Artificial vital organs and medical bionics: Market dynamics
FIG. 4 Key Opportunities Prioritized
FIG. 5 Artificial vital organs and medical bionics market - Porter’s analysis
FIG. 6 Artificial vital organs and medical bionics market - PESTEL analysis
FIG. 7 Artificial vital organ and medical bionics revenue share, by product, 2014 & 2022
FIG. 8 Artificial vital organs market, 2012 - 2022 (USD Million)
FIG. 9 Artificial heart market, 2012 - 2022 (USD Million)
FIG. 10 Artificial kidney market, 2012 - 2022 (USD Million)
FIG. 11 Artificial liver market, 2012 - 2022 (USD Million)
FIG. 12 Artificial pancreas market, 2012 - 2022 (USD Million)
FIG. 13 Artificial lungs market, 2012 - 2022 (USD Million)
FIG. 14 Heart-lung bypass machines market, 2012 - 2022 (USD Million)
FIG. 15 Oxygenators market, 2012 - 2022 (USD Million)
FIG. 16 Medical bionics market, 2012 - 2022 (USD Million)
FIG. 17 Ear bionics market, 2012 - 2022 (USD Million)
FIG. 18 Vision bionics market, 2012 - 2022 (USD Million)
FIG. 19 Exoskeletons market, 2012 - 2022 (USD Million)
FIG. 20 Bionic limbs market, 2012 - 2022 (USD Million)
FIG. 21 Bionic leg market, 2012 - 2022 (USD Million)
FIG. 22 Bionic hand market, 2012 - 2022 (USD Million)
FIG. 23 Brain bionics market, 2012 - 2022 (USD Million)
FIG. 24 Spinal cord stimulators market, 2012 - 2022 (USD Million)
FIG. 25 Deep brain stimulators market, 2012 - 2022 (USD Million)
FIG. 26 Vagus nerve stimulators market, 2012 - 2022 (USD Million)
FIG. 27 Cardiac bionics market, 2012 - 2022 (USD Million)
FIG. 28 Ventricular assist device market, 2012 - 2022 (USD Million)
FIG. 29 Left ventricular assist devices market, 2012 - 2022 (USD Million)
FIG. 30 Right ventricular assist devices market, 2012 - 2022 (USD Million)
FIG. 31 Heart valves market, 2012 - 2022 (USD Million)
FIG. 32 Mechanical heart valves market, 2012 - 2022 (USD Million)
FIG. 33 Biological tissue valves market, 2012 - 2022 (USD Million)
FIG. 34 Transcatheter heart valves market, 2012 - 2022 (USD Million)
FIG. 35 Artificial vital organ and medical bionics revenue share, by product, 2012 & 2022
FIG. 36 North America artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
FIG. 37 Europe artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
FIG. 38 Asia Pacific artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)
FIG. 39 RoW artificial vital organs and medical bionics market, 2012 - 2022 (USD Million)